Rothschild Investment »

Abcellera Biologics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2025-09-30 $80k 16k 5.03

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Jpmorgan Chase & Co Stock (JPM)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Blackstone Stock (BX)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Invesco Rafi Us 1000 Etf Etf (PRF)
Amazon Stock (AMZN)
Abbvie Stock (ABBV)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Meta Platforms Inc Cl A Stock (META)
Oracle Corp Stock (ORCL)
Chevron Corp Stock (CVX)
Costco Whsl Corp Stock (COST)

View all positions for Rothschild Investment

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Baillie Gifford & Co
Two Sigma Investments
Two Sigma Advisers
Arrowpoint Asset Management
BlackRock
Renaissance Technologies
Tang Capital Management
UBS Group
Millennium Management
Susquehanna International
Guardian Partners
Driehaus Capital Management
Citadel Advisors

View all funds holding Abcellera Biologics